Browse by Academic Unit (A-Z)

Export as [feed] Atom [feed] RSS
Group by: Creators Name | Item Type
Jump to: A | D | G | S | T
Number of items at this level: 7.


Alaggio, R., Amador, C., Anagnostopoulos, I. et al. (307 more authors) (2023) Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748. Leukemia, 37 (9). pp. 1944-1951. ISSN 0887-6924


Davies, J.R., Hilton, L.K., Jiang, A. et al. (13 more authors) (2023) Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL. Blood Advances. ISSN 2473-9529


Godson, L., Alemi, N., Nsengimana, J. et al. (6 more authors) (2022) Weakly-supervised learning for image-based classification of primary melanomas into genomic immune subgroups. In: Proceedings of Machine Learning Research. International Conference on Medical Imaging with Deep Learning, 06-08 Jul 2022, Zurich, Switzerland. , pp. 423-440.

Greenhalgh, T., Katzourakis, A., Wyatt, T.D. et al. (1 more author) (2022) Rapid evidence review to inform safe return to campus in the context of coronavirus disease 2019 (COVID-19). Wellcome Open Research, 6. 282. ISSN 2398-502X


Shaw, G., Cavalcante, L., Giles, F.J. et al. (1 more author) (2022) Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells. Journal of Hematology & Oncology, 15. 134. ISSN 1756-8722


Tanner, G., Finetti, M.A., Pollock, S. et al. (13 more authors) (2022) IDHwt Glioblastomas Show Opposing Resistance Mechanisms Across Patients in Response to Standard Treatment. In: BNOS 2022, 22-24 Jun 2022, Liverpool.

Teagle, A.R., Castro-Sanchez, P., Brownlie, R.J. et al. (5 more authors) (2023) Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion. Journal for ImmunoTherapy of Cancer, 11 (12). e007614. ISSN 2051-1426

This list was generated on Fri Mar 1 04:12:06 2024 GMT.